I'm not sure that everyone understands the study. The NPV midpoint at 8% is about the current market cap inclusive of stage 2. That means it is fully priced at about 20-25c allowing for the value of the prospects.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025